Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Gilead Sciences Inc (GILD)

62.25   0 (0%) 09-27 22:46
Open: 62.1 Pre. Close: 62.25
High: 62.505 Low: 61.765
Volume: 7,142,839 Market Cap: 78,044M
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The company is headquartered in Foster City, California and currently employs 11,000 full-time employees. The firm's portfolio of products and pipeline of investigational drugs includes treatments for Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS), liver diseases, cancer, inflammatory and respiratory diseases and cardiovascular conditions. Its products for HIV/AIDS patients include Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Truvada, Emtriva, Tybost and Vitekta. Its products for patients with liver diseases include Vemlidy, Epclusa, Harvoni, Sovaldi, Viread and Hepsera. The company offers Zydelig to patients with hematology/oncology diseases. Its products for patients with various cardiovascular diseases include Letairis, Ranexa and Lexiscan. Its products for various inflammation/respiratory diseases include Cayston and Tamiflu. The company had operations in more than 30 countries, as of December 31, 2016.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 62.656 - 63.071 63.071 - 63.446
Low: 60.718 - 61.256 61.256 - 61.741
Close: 61.428 - 62.266 62.266 - 63.024

Technical analysis

as of: 2020-09-25 4:30:34 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 76.53     One year: 79.33
Support: Support1: 61.65    Support2: 51.29
Resistance: Resistance1: 65.52    Resistance2: 67.92
Pivot: 64.50
Moving Average: MA(5): 63.04     MA(20): 64.90
MA(100): 71.98     MA(250): 70.12
MACD: MACD(12,26): -1.41     Signal(9): -1.29
Stochastic oscillator: %K(14,3): 6.99     %D(3): 6.20
RSI: RSI(14): 30.92
52-week: High: 85.97  Low: 60.89  Change(%): -1.8
Average Vol(K): 3-Month: 869371  10-Days: 975693

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
GILD has closed above bottom band by 7.0%. Bollinger Bands are 17.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Sun, 27 Sep 2020
Reflecting on Gilead Sciences’ (NASDAQ:GILD) Share Price Returns Over The Last Five Years - Simply Wall St

Fri, 25 Sep 2020
The Unprecedented Rise of Gilead Sciences Inc. (NASDAQ:GILD) - The Oracle Dispatch

Fri, 25 Sep 2020
Gilead Sciences: Debt Fueled Bottom - Seeking Alpha

Thu, 24 Sep 2020
Is Gilead Sciences Inc. (GILD) a Keeper? - The News Heater

Wed, 23 Sep 2020
Gilead Sciences Prices $7.25 Billion of Senior Unsecured Notes - Yahoo Finance

Tue, 15 Sep 2020
Gilead Sciences (GILD) Stock Sinks As Market Gains: What You Should Know - Yahoo Finance

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Drug Manufacturers General
Shares Out. (M) 1,250
Shares Float (M) 1,250
% Held by Insiders 0.41
% Held by Institutions 80.77
Shares Short (K) 16,170
Shares Short P. Month (K) 21,330

Stock Financials

EPS -0.200
EPS Est This Year 8.790
EPS Est Next Year 7.340
Book Value (p.s.) 14.380
Profit Margin -1.16
Operating Margin 18.80
Return on Assets (ttm) 4.4
Return on Equity (ttm) -1.4
Qtrly Rev. Growth -9.5
Gross Profit (p.s.) 14.216
Sales Per Share 17.736
EBITDA (p.s.) 4.448
Qtrly Earnings Growth
Operating Cash Flow (M) 9,230
Levered Free Cash Flow (M) 4,070

Stock Valuations

PE Ratio -311.25
PEG Ratio 0.42
Price to Book value 4.33
Price to Sales 3.51
Price to Cash Flow 8.43

Stock Dividends

Dividend 2.620
Forward Dividend 2.720
Dividend Yield 0.04
Dividend Pay Date 2020-09-28
Ex-Dividend Date 2020-09-13
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.